Community pharmacists are well-placed to report adverse drug reactions (ADRs) via yellow cards but often fall behind hospital colleagues in the number of reports submitted. One reason may be not knowing what to report.

MHRA guidelines

MHRA guidelines on what should be reported include:
• Serious reactions
• Anything that involves a medicine on additional monitoring
• An unlisted reaction in product information
• Anything you are unsure about reporting.

It is often asked ‘what constitutes a serious reaction’? An ADR which was fatal or life-threatening would be obviously classified as serious. However, there are other categories of serious reaction: these might include an ADR that results in hospitalisation or a prolonged hospital stay; one that results in disablement; or those causing congenital abnormalities.

Medically significant ADRs are also classified as serious reactions. These are those that do not meet the other criteria but where the ADR might result in harm to the patient and might require treatment.

Causality does not need to be established when submitting a yellow card. The MHRA’s guidance is, if in doubt – report it. So how can community pharmacists increase reporting?

The conversations community pharmacists have with their patients make them ideally placed to identify any ADRs:
• MUR and NMS consultations are specifically designed to highlight any issues a patient might be having with their medicine, including ADRs, leading to a yellow card report
• As suppliers of herbal and OTC medicines, pharmacists can identify any issues when talking to patients about these drugs
• Patients may not be aware that they can report ADRs. By talking to patients, running yellow card awareness events, and having the reporting telephone number and website address on hand, reporting may be increased.

Useful sources

Increasing your knowledge about ADRs and yellow cards and that of your team will also help. Useful sources of further information include:
• CPPE’s e-learning course for pharmacy professionals on ADRs, yellow cards and pharmacovigilance:
• MHRA guidance on the yellow card scheme for healthcare professionals:
• Signing up for monthly updates at
• The yellow card mobile phone app, which allows a watch list to be created to receive medication alerts and yellow cards to be submitted.

The MHRA guidance is – if in doubt, report it


UKCPA: Mothers and epilepsy

The safest policy for a mother with epilepsy and her baby is for her to take the medication and be seizure-free.

CPPE: Do you have the right skill mix in your pharmacy?

CPPE’s updated ‘Skill mix’ e-learning programme will help pharmacists conduct an effective skill mix review


PSNC paints pessimistic picture for the future

The impact of the funding cuts in England is going to hit contractors hard in November, PSNC has warned

Schools now able to purchase AAIs

Schools can now purchase adrenaline auto-injectors without a prescription for emergency use

Are there barriers to women leaders in pharmacy?

With a number of pharmacy organisations with few or no women on their elected boards, what might be stopping more women ...